PLOD1 and polycystic ovary syndrome: Ninety-two percent of women with PCOS achieved menstrual cycle recovery (defined as the return of regular menstrual cycles) and showed a significant improvement in biological markers (such as LH, FSH, estradiol, progesterone, total testosterone, SHBG and FAI) when they received combination therapy with liraglutide and metformin (62).